-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on Immunocore Holdings, Lowers Price Target to $50

Benzinga·04/14/2025 16:04:00
Listen to the news
JP Morgan analyst Jessica Fye maintains Immunocore Holdings (NASDAQ:IMCR) with a Overweight and lowers the price target from $54 to $50.